E. Ararat Et Al. , "How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer," JOURNAL OF BUON , vol.16, no.2, pp.377, 2011
Ararat, E. Et Al. 2011. How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer. JOURNAL OF BUON , vol.16, no.2 , 377.
Ararat, E., Sahin, I., & Altundag, K., (2011). How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer. JOURNAL OF BUON , vol.16, no.2, 377.
Ararat, E., I. Sahin, And K. Altundag. "How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer," JOURNAL OF BUON , vol.16, no.2, 377, 2011
Ararat, E. Et Al. "How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer." JOURNAL OF BUON , vol.16, no.2, pp.377, 2011
Ararat, E. Sahin, I. And Altundag, K. (2011) . "How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer." JOURNAL OF BUON , vol.16, no.2, p.377.
@article{article, author={E. Ararat Et Al. }, title={How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer}, journal={JOURNAL OF BUON}, year=2011, pages={377} }